AACR Stories
A grant from the AACR helped Yale University cancer scientist Luisa Escobar-Hoyos, MSc, PhD, earn two major, multi-year federal grants to advance her research to better treat pancreatic and lung cancers.
Learn More
A grant from the AACR helped Yale University cancer scientist Luisa Escobar-Hoyos, MSc, PhD, earn two major, multi-year federal grants to advance her research to better treat pancreatic and lung cancers.
Learn More
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreThe inaugural AACR Pediatric Cancer Progress Report highlights research-driven advances in the prevention, detection, and treatment of childhood cancers.
Read the ReportMore than 330,000 men in the U.S. will be diagnosed with prostate cancer this year. September is Prostate Cancer Awareness Month. Read about prevention, screening, and treatment options for this type of cancer.
Learn MoreResearchers are shedding light on the multifaceted ways that extrachromosomal DNA impacts cancer development and resistance to targeted therapies.
Learn MoreUseful information for cancer patients and their families, survivors, caregivers, advocates, and others from Cancer Today magazine.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSession recordings are available for viewing to registered attendees through October 31. Registration remains open for the on-demand virtual meeting.
The AACR Cancer Disparities Progress Report 2026 provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Learn MoreThe AACR and its more than 65,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 65,000 members worldwide drive progress against cancer.
Donate Now
